NasdaqGM - Nasdaq Real Time Price USD

Ultralife Corporation (ULBI)

10.71 +1.98 (+22.68%)
At close: 4:00 PM EDT
10.65 -0.06 (-0.56%)
After hours: 4:39 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts --1--1
Avg. Estimate 00.100.69
Low Estimate 00.100.69
High Estimate 00.100.69
Year Ago EPS -0.01-0.01----

Revenue Estimate

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts 1111
Avg. Estimate 44.55M38M158.64M169.5M
Low Estimate 39M38M153.1M169.5M
High Estimate 39M38M153.1M169.5M
Year Ago Sales 36.11M27M131.84M158.64M
Sales Growth (year/est) 23.40%40.70%20.30%6.80%

Earnings History

CURRENCY IN USD 9/30/2022 3/31/2023 6/30/2023 9/30/2023
EPS Est. 0.04-0.10.040.1
EPS Actual -0.01-0.010.290.1
Difference -0.050.090.250
Surprise % -125.00%90.00%625.00%0.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate 00.100.69
7 Days Ago 0.090.10.450.69
30 Days Ago 0.090.10.450.69
60 Days Ago 0.090.10.450.68
90 Days Ago 0.090.10.450.68

EPS Revisions

CURRENCY IN USD Current Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD ULBIIndustrySectorS&P 500
Current Qtr. ------2.60%
Next Qtr. 1,100.00%----13.40%
Current Year ------5.20%
Next Year ------13.30%
Next 5 Years (per annum) 17.50%----11.11%
Past 5 Years (per annum) -4.87%------

Research Analysis

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Benchmark: Buy to Buy 3/5/2024
Reiterates Benchmark: Buy to Buy 8/8/2023
Initiated Benchmark: Buy 3/26/2021
Downgrade Ardour Capital: Hold to Reduce 5/2/2013

Related Tickers